30 Results for "

rosiglitazone

" in MedChemExpress (MCE) Product Catalog:
Products (30)

30 Results for "rosiglitazone" in MCE Product Catalog:

189
189 Publications Verification
Cat. No.: HY-17386
CAS No.: 122320-73-4
Synonyms: BRL 49653
Rosiglitazone (BRL 49653) is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM), with blood-brain barrier permeability. Rosiglitazone is an TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone can be used in the research of obesity and diabetes, senescence, ovarian cancer .
loading...
    loading...
189
189 Publications Verification
Cat. No.: HY-14600
CAS No.: 155141-29-0
Purity:  99.73%
Synonyms: BRL 49653C
Rosiglitazone maleate (BRL 49653C) is a potent and selective activator of PPARγ, with EC50s of 30 nM, 100 nM and 60 nM for PPARγ1, PPARγ2, and PPARγ, respectively, and a Kd of appr 40 nM for PPARγ; Rosiglitazone maleate is also an modulator of TRP channels, inhibits TRP melastatin 2 (TRPM2), TRPM3 and activates TRP canonical 5 (TRPC5).
loading...
    loading...
189
189 Publications Verification
Cat. No.: HY-17386A
CAS No.: 302543-62-0
Synonyms: BRL 49653 hydrochloride
Rosiglitazone (BRL 49653) hydrochloride is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone hydrochloride is a TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone hydrochloride can be used in the research of obesity and diabetes, senescence, ovarian cancer .
loading...
    loading...
186
186 Cited Publications
Cat. No.: HY-17386B
CAS No.: 316371-84-3
Synonyms: BRL 49653 potassium
Rosiglitazone (BRL 49653) potassium is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone potassium is a TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone potassium can be used in the research of obesity and diabetes, senescence, ovarian cancer .
loading...
    loading...
Cat. No.: HY-114853
CAS No.: 756813-87-3
Target:  

PPAR

Research Areas:  

Metabolic Disease

BVT.13 is an orally active and selective PPARγ agonist with a maximal efficacy similar to that of Rosiglitazone (HY-17386). In addition, BVT.13 exhibits antidiabetic activity in ob/ob mice .
loading...
    loading...
Cat. No.: HY-101064S3
CAS No.: 1190594-22-9
Purity:  98.90%
Fmoc-leucine-d10 is the deuterium labeled Fmoc-leucine. Fmoc-leucine is a selective PPARγ modulator. Fmoc-leucine activates PPARγ with a lower potency but a similar maximal efficacy than rosiglitazone. Fmoc-leucine improves insulin sensitivity in normal, diet-induced glucose-intolerant, and in diabetic db/db mice. Fmoc-leucine has a lower adipogenic activity .
loading...
    loading...
Cat. No.: HY-17386R
CAS No.: 122320-73-4
Synonyms: BRL 49653 (Standard)
Rosiglitazone (Standard) is the analytical standard of Rosiglitazone. This product is intended for research and analytical applications. Rosiglitazone (BRL 49653) is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone is an TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone can be used in the research of obesity and diabetes, senescence, ovarian cancer .
loading...
    loading...
Cat. No.: HY-112247
CAS No.: 2088135-12-8
Purity:  99.89%
SR 16832 is a dual-site covalent, orthosteric and allosteric PPARγ antagonist. SR 16832 activates the TGF-β signaling pathway and upregulates the expression of Vimentin and Fibronectin (Fibronectin). SR 16832 is toxic to bronchial epithelium. SR 16832 can be used in research related to type 2 diabetes and pulmonary fibrosis .
loading...
    loading...
Cat. No.: HY-101064S2
CAS No.: 538372-74-6
Purity:  98.50%
Synonyms: N-FMOC-leucine-d3; NPC 15199-d3; NSC 334290-d3
Fmoc-leucine-d3 is the deuterium labeled Fmoc-leucine. Fmoc-leucine is a selective PPARγ modulator. Fmoc-leucine activates PPARγ with a lower potency but a similar maximal efficacy than rosiglitazone. Fmoc-leucine improves insulin sensitivity in normal, diet-induced glucose-intolerant, and in diabetic db/db mice. Fmoc-leucine has a lower adipogenic activity .
loading...
    loading...
Cat. No.: HY-17386S1
CAS No.: 1132641-21-4
Synonyms: BRL 49653-d4
Rosiglitazone-d4 is deuterated labeled Rosiglitazone (HY-17386). Rosiglitazone (BRL 49653) is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone is an TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone can be used in the research of obesity and diabetes, senescence, ovarian cancer .
loading...
    loading...
Cat. No.: HY-101064S1
CAS No.: 1163133-36-5
Fmoc-leucine- 13C6, 15N is a 15N-labeled and 13C-labled Fmoc-leucine. Fmoc-leucine is a selective PPARγ modulator. Fmoc-leucine activates PPARγ with a lower potency but a similar maximal efficacy than rosiglitazone. Fmoc-leucine improves insulin sensitivity
loading...
    loading...
Cat. No.: HY-17386S
CAS No.: 1132641-22-5
Rosiglitazone-d3 is the deuterium labeled Rosiglitazone. Rosiglitazone (BRL 49653) is a selective, orally active PPARγ agonist with EC50s of 30 nM, 100 nM and 60 nM for PPARγ1, PPARγ2, and PPARγ, respectively. Rosiglitazone binds to PPARγ with a Kd of approximately 40 nM. Rosiglitazone is also an activator of TRPC5 (EC50=~30 μM) and an inhibitor of TRPM3 .
loading...
    loading...
Cat. No.: HY-14792C
CAS No.: 1048002-36-3
Synonyms: Efatutazone hydrochloride hydrate; CS-7017 hydrochloride hydrate; RS5444 hydrochloride hydrate
Target:  

PPAR

Research Areas:  

Cancer

Inolitazone hydrochloride hydrate (Efatutazone hydrochloride hydrate) is a novel PPARγ high-affinity agonist, with an EC50 value one-fiftieth that of Rosiglitazone (HY-17386), and shows no inhibitory effect on RIE cells that do not express PPARγ. Inolitazone hydrochloride hydrate can be used in the research of cancer .
loading...
    loading...
Cat. No.: HY-150993S
CAS No.: 1215168-64-1
Rosiglitazone-d5 (maleate) is the deuterium labeled Rosiglitazone maleate .
loading...
    loading...
Cat. No.: HY-144155S
CAS No.: 1246817-46-8
5-Hydroxy Rosiglitazone-d4 is the deuterium labeled 5-Hydroxy Rosiglitazone .
loading...
    loading...
Cat. No.: HY-144155S1
CAS No.: 1794759-89-9
5-Hydroxy Rosiglitazone-d4-1 is the deuterium labeled 5-Hydroxy Rosiglitazone .
loading...
    loading...
Cat. No.: HY-17386AR
CAS No.: 302543-62-0
Synonyms: BRL 49653 hydrochloride (Standard)
Rosiglitazone (hydrochloride) (Standard) is the analytical standard of Rosiglitazone (hydrochloride). This product is intended for research and analytical applications. Rosiglitazone (BRL 49653) hydrochloride is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone hydrochloride is a TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone hydrochloride can be used in the research of obesity and diabetes, senescence, ovarian cancer .
loading...
    loading...
Cat. No.: HY-118788S
CAS No.: 1215407-67-2
Synonyms: SB 237216-d4
N-Desmethyl rosiglitazone-d4 is the deuterium labeled N-Desmethyl rosiglitazone .
loading...
    loading...
Cat. No.: HY-14600R
CAS No.: 155141-29-0
Synonyms: BRL 49653C (Standard)
Rosiglitazone (maleate) (Standard) is the analytical standard of Rosiglitazone (maleate). This product is intended for research and analytical applications. Rosiglitazone maleate (BRL 49653C) is a potent and selective activator of PPARγ, with EC50s of 30 nM, 100 nM and 60 nM for PPARγ1, PPARγ2, and PPARγ, respectively, and a Kd of appr 40 nM for PPARγ; Rosiglitazone maleate is also an modulator of TRP channels, inhibits TRP melastatin 2 (TRPM2), TRPM3 and activates TRP canonical 5 (TRPC5).
loading...
    loading...
Cat. No.: HY-118788
CAS No.: 257892-31-2
Synonyms: SB 237216
N-Desmethyl rosiglitazone (SB 237216) is a metabolite of Rosiglitazone (HY-17386), generated through demethylation by the cytochrome P450 enzyme system in liver microsomes. It retains partial PPARγ agonist activity and supports studies on the metabolism and pharmacokinetics of Rosiglitazone (HY-17386) .
loading...
    loading...